Last century the medicine market developed strongly. Medicines are beneficial to our society, but they can also harm, take lives and hamper the standard of living. Pharmaceutical companies are widely criticised by authors who warn against a possible pharmageddon.
The experiences with medicine disasters pushed for laws and control mechanisms of the medicine market. The aim is to pursue an environment in which medicines have a positive risk benefit balance. As an extra safeguard, a governmental co-responsibility is created by establishing regulatory authorities who play nowadays a role of vital importance. In this book Matthias van Gelder describes the responsibility of medicine regulatory authorities. The main question is under what circumstances a regulatory authority can be held liable under civil liability when it makes ‘mistakes’ through which dangerous medicines enter the market or stay – too long – on the market.